Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-03-09, Stock:NVS, The news for the past five days is as follows:
2018-03-02: NEWS1: Wall Street More Optimistic about Johnson & Johnson after 4Q17.NEWS2: Sanofi’s Generics and Consumer Healthcare Portfolios in 4Q17.NEWS3: Sanofi’s Established Prescription Products in 4Q17.NEWS4: Novartis Shareholders Approve All Resolutions At AGM - Quick Facts.NEWS5: Novartis Shareholders Approve All Resolutions At AGM - Quick Facts.
2018-03-05: NEWS1: Bullish Two Hundred Day Moving Average Cross - NVS.NEWS2: Bullish Two Hundred Day Moving Average Cross - NVS.NEWS3: Here's Why Dermira Fell as Much as 64.2% Today.NEWS4: Here's Why Dermira Fell as Much as 64.2% Today.NEWS5: Aduro (ADRO) Q4 Loss Narrower Than Expected, Revenues Miss.NEWS6: Aduro (ADRO) Q4 Loss Narrower Than Expected, Revenues Miss.NEWS7: Noteworthy ETF Inflows: VEA, NSRGY, NVS, RDS.B.NEWS8: Noteworthy ETF Inflows: VEA, NSRGY, NVS, RDS.B.NEWS9: What's in Store for Conatus (CNAT) This Earnings Season?.NEWS10: What's in Store for Conatus (CNAT) This Earnings Season?.NEWS11: Greek parliament set to probe politicians in alleged Novartis bribery case.NEWS12: Sanofi’s Valuations in February 2018.NEWS13: Johnson & Johnson Stock: What’s behind the Recent Decline?.NEWS14: The Swiss Stock Market Staged A Strong Recovery.NEWS15: The Swiss Stock Market Staged A Strong Recovery.
2018-03-06: NEWS1: Glaxo's Encouraging Asthma & HIV Data at Medical Meetings.NEWS2: Glaxo's Encouraging Asthma & HIV Data at Medical Meetings.NEWS3: The Swiss Stock Market Pulled Back As Novartis Weighs.NEWS4: The Swiss Stock Market Pulled Back As Novartis Weighs.
2018-03-07: NEWS1: Pharmaceutical Industry Outlook - March 2018.NEWS2: Pharmaceutical Industry Outlook - March 2018.NEWS3: Pharmaceutical Industry Outlook - March 2018.NEWS4: Analyzing Gilead Sciences’ Other Products in 4Q17.NEWS5: Johnson & Johnson’s Consumer Segment in 4Q17.NEWS6: How Bristol-Myers Squibb’s Sprycel and Empliciti Performed in 4Q17.NEWS7: The Swiss Stock Market Finished Higher After Late Recovery.NEWS8: The Swiss Stock Market Finished Higher After Late Recovery.NEWS9: Novartis, U.S. partner plan remote trials to boost participation.NEWS10: Novartis, Science 37 Commit To Launch Up To 10 Trials Over Three Years.NEWS11: Novartis, Science 37 Commit To Launch Up To 10 Trials Over Three Years.
2018-03-08: NEWS1: Conatus (CNAT) Loss Narrower Than Expected in Q4, Sales Miss.NEWS2: Conatus (CNAT) Loss Narrower Than Expected in Q4, Sales Miss.NEWS3: Conatus (CNAT) Loss Narrower Than Expected in Q4, Sales Miss.NEWS4: Merck to Pay $300M Upfront to Co-Develop Eisai's Cancer Drug.NEWS5: Merck to Pay $300M Upfront to Co-Develop Eisai's Cancer Drug.NEWS6: The Swiss Stock Market Climbed As Trade Concerns Ease.NEWS7: The Swiss Stock Market Climbed As Trade Concerns Ease.NEWS8: [$$] Syriza is undermining democracy in Greece.

Answer: Rise